Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024

分子品質管理の世界市場予測(~2024年)

◆タイトル:Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024
◆商品コード:MD 6900
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年2月20日
◆ページ数:126
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

分子品質管理の世界市場は、2018年の1億3,200万米ドルから2024年には2億3,700万米ドルに達し、この期間中10.2%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、サードパーティの品質管理の採用の増加、認定臨床検査機関の数の増加、および外部品質評価サポートに対する需要の高まりなどが考えられます。一方で、品質管理プロセスに伴う高コスト、病院や研究機関における予算上の制約、そして分子検査に関連する不利な払い戻し条件により、市場の成長が抑制される可能性があります。当調査レポートでは、分子品質管理の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品(独立型、ツール固有)分析、検体の種類(単一検体、複数検体)分析、用途(感染症)分析、エンドユーザー(IVDメーカー、研究機関)分析、分子品質管理の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market.”The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.
“The infectious diseases segment held the largest share of the molecular controls market in 2018.”

Based on application, the molecular controls market is divided into four major segments—infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018. The large share of this segment is attributed to the development of advanced assays for different infectious diseases, significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the molecular quality controls market.
By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%

Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The study includes an in-depth competitive analysis of these key players in the molecular quality controls market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the molecular quality controls market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, analyte type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall molecular quality controls market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS COVERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY SOURCES 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY SOURCES 19
2.1.2.1 Key data from primary sources 20
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.3.1.1 Key industry insights 23
3 EXECUTIVE SUMMARY 24
3.1 INTRODUCTION 24
4 PREMIUM INSIGHTS 28
4.1 MOLECULAR QUALITY CONTROLS: MARKET OVERVIEW 28
4.2 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT 29
4.3 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER (2018) 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.1.1 DRIVERS 32
5.1.1.1 Increasing number of accredited clinical laboratories 32
5.1.1.2 Growing adoption of third-party quality controls 33
5.1.1.3 Rising demand for external quality assessment support 33
5.1.2 RESTRAINTS 34
5.1.2.1 Additional costs involved in quality control and budget constraints in hospitals and laboratories 34
5.1.2.2 Unfavorable reimbursement scenario for molecular tests 34

5.1.3 OPPORTUNITIES 34
5.1.3.1 Rising demand for multi-analyte controls 34
5.1.4 CHALLENGES 35
5.1.4.1 Lack of mandatory regulations for clinical laboratory accreditation in several emerging countries 35
5.1.4.2 Complex regulatory frameworks 35
6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT 36
6.1 INTRODUCTION 37
6.2 INDEPENDENT CONTROLS 37
6.2.1 WIDE RANGE OF APPLICATIONS AND REDUCTIONS IN OPERATIONAL COSTS HAVE BOOSTED THE USE OF INDEPENDENT CONTROLS 37
6.3 INSTRUMENT-SPECIFIC CONTROLS 39
6.3.1 PCR 40
6.3.1.1 PCR controls dominate the instrument-specific controls market 40
6.3.2 DNA SEQUENCING & NGS 41
6.3.2.1 Advancements in sequencing technologies form a positive growth factor for this market 41
6.3.3 OTHER TECHNOLOGIES 43
7 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE 44
7.1 INTRODUCTION 45
7.2 SINGLE-ANALYTE CONTROLS 45
7.2.1 SIGNIFICANT USE OF SINGLEPLEX ASSAYS IN HOSPITALS—A KEY MARKET DRIVER 45
7.3 MULTI-ANALYTE CONTROLS 47
7.3.1 INCREASING PREFERENCE FOR MULTI-ANALYTE CONTROLS TO FUEL MARKET GROWTH 47
8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION 49
8.1 INTRODUCTION 50
8.2 INFECTIOUS DISEASES 51
8.2.1 DEMAND FOR INFECTIOUS DISEASE TESTING CONTROLS HAS GROWN STEADILY 51
8.3 ONCOLOGY 52
8.3.1 GROWING CANCER PREVALENCE AND TECHNOLOGICAL ADVANCEMENTS ARE KEY GROWTH DRIVERS IN THIS SEGMENT 52
8.4 GENETIC TESTING 53
8.4.1 ADVANCEMENTS IN GENETIC TESTING DRIVE THE MARKET 53
8.5 OTHER APPLICATIONS 55

9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER 56
9.1 INTRODUCTION 57
9.2 CLINICAL LABORATORIES 57
9.2.1 INCREASING NUMBER OF ACCREDITED CLINICAL LABORATORIES TO PROVIDE GROWTH OPPORTUNITIES IN THE COMING YEARS 57
9.3 HOSPITALS 59
9.3.1 GROWING PATIENT VOLUME DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS IN HOSPITAL-BASED LABORATORIES 59
9.4 IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS 60
9.4.1 ADVANCEMENTS IN MOLECULAR TECHNOLOGIES DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS AMONG IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS 60
9.5 ACADEMIC & RESEARCH INSTITUTES 61
9.5.1 INCREASING DEMAND FOR ENSURING THE ACCURACY OF DIAGNOSTIC TESTS TO SUPPORT THE GROWTH OF THIS END-USER SEGMENT 61
9.6 OTHER END USERS 63
10 MOLECULAR QUALITY CONTROLS MARKET, BY REGION 64
10.1 INTRODUCTION 65
10.2 NORTH AMERICA 66
10.2.1 US 70
10.2.1.1 Increasing CLIA accreditation for clinical laboratories driving the market for molecular quality controls in the US 70
10.2.2 CANADA 72
10.2.2.1 Government investments supporting the development of advanced diagnostic procedures for infectious diseases and cancer in Canada 72
10.3 EUROPE 75
10.3.1 GROWING DEMAND FOR EXTERNAL QUALITY CONTROL SUPPORT FROM END USERS WILL PROVIDE GROWTH OPPORTUNITIES 75
10.4 ASIA PACIFIC 77
10.4.1 STRATEGIC DEVELOPMENTS BY LEADING PLAYERS TO DRIVE THE MARKET FOR MOLECULAR QUALITY CONTROLS IN APAC 77
10.5 REST OF THE WORLD 81
11 COMPETITIVE LANDSCAPE 84
11.1 MARKET OVERVIEW 84
11.2 MARKET RANKING ANALYSIS, 2017 84
11.2.1 COMPETITIVE LEADERSHIP MAPPING 85
11.2.2 VISIONARY LEADERS 85
11.2.3 INNOVATORS 85
11.2.4 DYNAMIC DIFFERENTIATORS 85
11.2.5 EMERGING COMPANIES 85

11.3 COMPETITIVE BENCHMARKING 87
11.3.1 STRENGTH OF PRODUCT PORTFOLIO (15 PLAYERS) 87
11.3.2 BUSINESS STRATEGY EXCELLENCE (15 PLAYERS) 88
12 COMPANY PROFILES 89
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 SERACARE LIFE SCIENCES INC. 89
12.2 THERMO FISHER SCIENTIFIC 93
12.3 BIO-RAD LABORATORIES 98
12.4 MICROBIOLOGICS INC. 100
12.5 ZEPTOMETRIX 104
12.6 ROCHE DIAGNOSTICS 108
12.7 ABBOTT LABORATORIES 110
12.8 QUIDEL 112
12.9 QNOSTICS 114
12.10 MAINE MOLECULAR QUALITY CONTROLS INC. 117
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 119
13.1 DISCUSSION GUIDE 119
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 122
13.3 AVAILABLE CUSTOMIZATIONS 124
13.4 RELATED REPORTS 124
13.5 AUTHOR DETAILS 125

LIST OF TABLES

TABLE 1 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 37
TABLE 2 INDEPENDENT CONTROLS MARKET, BY REGION, 2016–2024 (USD MILLION) 38
TABLE 3 NORTH AMERICA: INDEPENDENT CONTROLS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 38
TABLE 4 INSTRUMENT-SPECIFIC CONTROLS MARKET, BY REGION,
2016–2024 (USD MILLION) 39
TABLE 5 NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 39
TABLE 6 INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 40
TABLE 7 INSTRUMENT-SPECIFIC CONTROLS MARKET FOR PCR, BY REGION,
2016–2024 (USD MILLION) 41
TABLE 8 NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR PCR,
BY COUNTRY, 2016–2024 (USD MILLION) 41
TABLE 9 INSTRUMENT-SPECIFIC CONTROLS MARKET FOR DNA SEQUENCING & NGS,
BY REGION, 2016–2024 (USD MILLION) 42
TABLE 10 NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2016–2024 (USD MILLION) 42
TABLE 11 INSTRUMENT-SPECIFIC CONTROLS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2016–2024 (USD MILLION) 43
TABLE 12 NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2024 (USD MILLION) 43
TABLE 13 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE,
2016–2024 (USD MILLION) 45
TABLE 14 SINGLE-ANALYTE CONTROLS MARKET, BY REGION, 2016–2024 (USD MILLION) 46
TABLE 15 NORTH AMERICA: SINGLE-ANALYTE CONTROLS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 46
TABLE 16 MULTI-ANALYTE CONTROLS MARKET, BY REGION, 2016–2024 (USD MILLION) 47
TABLE 17 NORTH AMERICA: MULTI-ANALYTE CONTROLS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 48
TABLE 18 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 50
TABLE 19 MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASES,
BY REGION, 2016–2024 (USD MILLION) 51
TABLE 20 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016–2024 (USD MILLION) 52
TABLE 21 MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY, BY REGION,
2016–2024 (USD MILLION) 52
TABLE 22 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY,
BY COUNTRY, 2016–2024 (USD MILLION) 53
TABLE 23 MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY REGION, 2016–2024 (USD MILLION) 54
TABLE 24 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2016–2024 (USD MILLION) 54
TABLE 25 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2024 (USD MILLION) 55
TABLE 26 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2024 (USD MILLION) 55
TABLE 27 MOLECULAR QUALITY CONTROLS MARKET, BY END USER,
2016–2024 (USD MILLION) 57
TABLE 28 MOLECULAR QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES,
BY REGION, 2016–2024 (USD MILLION) 58
TABLE 29 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2016–2024 (USD MILLION) 58
TABLE 30 MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY REGION,
2016–2024 (USD MILLION) 59
TABLE 31 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS,
BY COUNTRY, 2016–2024 (USD MILLION) 60
TABLE 32 MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2024 (USD MILLION) 61
TABLE 33 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS,
BY COUNTRY, 2016–2024 (USD MILLION) 61
TABLE 34 MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2024 (USD MILLION) 62
TABLE 35 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC
& RESEARCH INSTITUTES, BY COUNTRY, 2016–2024 (USD MILLION) 62
TABLE 36 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY REGION, 2016–2024 (USD MILLION) 63
TABLE 37 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2024 (USD MILLION) 63
TABLE 38 MOLECULAR QUALITY CONTROLS MARKET, BY REGION,
2016–2024 (USD MILLION) 66
TABLE 39 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 68
TABLE 40 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 68
TABLE 41 NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 68
TABLE 42 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016–2024 (USD MILLION) 69
TABLE 43 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016–2024 (USD MILLION) 69
TABLE 44 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016–2024 (USD MILLION) 69
TABLE 45 US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 70
TABLE 46 US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 71
TABLE 47 US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE,
2016–2024 (USD MILLION) 71
TABLE 48 US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 71
TABLE 49 US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER,
2016–2024 (USD MILLION) 72
TABLE 50 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 73
TABLE 51 CANADA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 73
TABLE 52 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE,
2016–2024 (USD MILLION) 73
TABLE 53 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 74
TABLE 54 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER,
2016–2024 (USD MILLION) 74
TABLE 55 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 75
TABLE 56 EUROPE: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 76
TABLE 57 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE,
2016–2024 (USD MILLION) 76
TABLE 58 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 76
TABLE 59 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER,
2016–2024 (USD MILLION) 77
TABLE 60 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 79
TABLE 61 ASIA PACIFIC: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 79
TABLE 62 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016–2024 (USD MILLION) 79
TABLE 63 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 80
TABLE 64 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER,
2016–2024 (USD MILLION) 80
TABLE 65 ROW: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 81
TABLE 66 ROW: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 81
TABLE 67 ROW: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE,
2016–2024 (USD MILLION) 82
TABLE 68 ROW: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 82
TABLE 69 ROW: MOLECULAR QUALITY CONTROLS MARKET, BY END USER,
2016–2024 (USD MILLION) 83


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 PRIMARY SOURCES 19
FIGURE 3 BOTTOM-UP APPROACH 21
FIGURE 4 TOP-DOWN APPROACH 21
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
FIGURE 6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2018 (USD MILLION) 24
FIGURE 7 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE,
2018 VS. 2024 (USD MILLION) 25
FIGURE 8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2018 (USD MILLION) 26
FIGURE 9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2018 26
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR QUALITY CONTROLS MARKET 27
FIGURE 11 MOLECULAR QUALITY CONTROLS MARKET TO REGISTER A DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD 28
FIGURE 12 INDEPENDENT CONTROLS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2024) 29
FIGURE 13 CLINICAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MOLECULAR QUALITY CONTROLS MARKET IN 2018 30
FIGURE 14 MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 31
FIGURE 15 NUMBER OF LABORATORIES THAT RECEIVED CLIA ACCREDITATION,
BY ACCREDITATION ORGANIZATION (2018) 32
FIGURE 16 GEOGRAPHIC SNAPSHOT: APAC WILL BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR QUALITY CONTROLS MARKET DURING THE FORECAST PERIOD 65
FIGURE 17 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT 67
FIGURE 18 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT 78
FIGURE 19 RANK OF COMPANIES IN THE GLOBAL MOLECULAR QUALITY CONTROLS
MARKET, 2017 84
FIGURE 20 MOLECULAR QUALITY CONTROLS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017 86
FIGURE 21 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 93
FIGURE 22 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017) 98
FIGURE 23 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2017) 108
FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017) 110
FIGURE 25 QUIDEL: COMPANY SNAPSHOT (2017) 112


★調査レポート[分子品質管理の世界市場予測(~2024年)] ( Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024 / MD 6900) 販売に関する免責事項
[分子品質管理の世界市場予測(~2024年)] ( Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024 / MD 6900) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆